---
title: "Sino Medical Sciences Technology Inc. (688108.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688108.SH.md"
symbol: "688108.SH"
name: "Sino Medical Sciences Technology Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T11:31:14.891Z"
locales:
  - [en](https://longbridge.com/en/quote/688108.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688108.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688108.SH.md)
---

# Sino Medical Sciences Technology Inc. (688108.SH)

## Company Overview

Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Sciences Technology Inc. was incorporated in 2007 and is headquartered in Tianjin, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.sinomed.com](https://www.sinomed.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.28)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.44% |  |
| Net Profit YoY | 1020.20% |  |
| P/B Ratio | 8.82 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8763295005.12 |  |
| Revenue | 565298202.72 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.39% | B |
| Profit Margin | 12.19% | B |
| Gross Margin | 69.81% | A |
| Revenue YoY | 20.44% | B |
| Net Profit YoY | 1020.20% | A |
| Total Assets YoY | 3.29% | C |
| Net Assets YoY | 18.01% | A |
| Cash Flow Margin | 266.85% | A |
| OCF YoY | 20.44% | B |
| Turnover | 0.43 | C |
| Gearing Ratio | 19.84% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sino Medical Sciences Technology Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.44%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "1020.20%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "8.82",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "8763295005.12",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "565298202.72",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.39%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "12.19%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "69.81%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "20.44%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "1020.20%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.29%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "18.01%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "266.85%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "20.44%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "19.84%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 127.18 | 46/64 | 983.17 | 293.94 | 223.83 |
| PB | 8.82 | 62/64 | 12.79 | 9.46 | 6.57 |
| PS (TTM) | 15.50 | 58/64 | 23.55 | 16.88 | 12.38 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-06-22T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.13 |
| Highest Target | 14.00 |
| Lowest Target | 14.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688108.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688108.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688108.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**